Travere Therapeutics
TVTX
TVTX
131 hedge funds and large institutions have $611M invested in Travere Therapeutics in 2019 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
131
Holders Change
+1
Holders Change %
+0.77%
% of All Funds
2.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
47
Reduced
43
Closed
20
Calls
$668K
Puts
$2.56M
Net Calls
-$1.89M
Net Calls Change
+$647K
Top Buyers
| 1 |
Millennium Management
New York
|
+$17.2M |
| 2 |
BlackRock
New York
|
+$5.74M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$5.52M |
| 4 |
D.E. Shaw & Co
New York
|
+$4.24M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$3.76M |
Top Sellers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$20.2M |
| 2 |
SCM
Scopia Capital Management
New York
|
-$17.2M |
| 3 |
BC
Broadfin Capital
New York
|
-$7.08M |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.89M |
| 5 |
PA
Perceptive Advisors
New York
|
-$5.4M |
